Antitubercular Agents
Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.
Culture Media
Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN.
Cell Wall
Microbial Sensitivity Tests
Mycobacterium tuberculosis
Coproporphyria, Hereditary
An autosomal dominant porphyria that is due to a deficiency of COPROPORPHYRINOGEN OXIDASE in the LIVER, the sixth enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features include both neurological symptoms and cutaneous lesions. Patients excrete increased levels of porphyrin precursors, 5-AMINOLEVULINATE and COPROPORPHYRINS.
Coproporphyrins
Coproporphyrinogen Oxidase
An enzyme that catalyzes the oxidative decarboxylation of coproporphyrinogen III to protoporphyrinogen IX by the conversion of two propionate groups to two vinyl groups. It is the sixth enzyme in the 8-enzyme biosynthetic pathway of HEME, and is encoded by CPO gene. Mutations of CPO gene result in HEREDITARY COPROPORPHYRIA.
Porphyrias, Hepatic
A group of metabolic diseases due to deficiency of one of a number of LIVER enzymes in the biosynthetic pathway of HEME. They are characterized by the accumulation and increased excretion of PORPHYRINS or its precursors. Clinical features include neurological symptoms (PORPHYRIA, ACUTE INTERMITTENT), cutaneous lesions due to photosensitivity (PORPHYRIA CUTANEA TARDA), or both (HEREDITARY COPROPORPHYRIA). Hepatic porphyrias can be hereditary or acquired as a result of toxicity to the hepatic tissues.
Porphyrias
A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.
Porphyrins
A group of compounds containing the porphin structure, four pyrrole rings connected by methine bridges in a cyclic configuration to which a variety of side chains are attached. The nature of the side chain is indicated by a prefix, as uroporphyrin, hematoporphyrin, etc. The porphyrins, in combination with iron, form the heme component in biologically significant compounds such as hemoglobin and myoglobin.
Porphyrinogens
Tuberculosis
Tuberculosis, Multidrug-Resistant
Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS.
Pregnancy
D-cycloserine increases positive symptoms in chronic schizophrenic patients when administered in addition to antipsychotics: a double-blind, parallel, placebo-controlled study. (1/293)
A hypofunction of the glutamatergic system and NMDA receptors in schizophrenia has been hypothesized. Therefore, stimulation of these receptors could be of benefit to patients with schizophrenia. D-cycloserine has been used for this purpose. This study reports the effects of 100 mg D-cycloserine, when added to typical antipsychotics in chronic schizophrenic patients exhibiting prominent negative symptoms, using a placebo-controlled, double-blind, parallel, design. D-cycloserine slightly worsened psychotic symptoms and general psychopathology as compared to placebo. D-cycloserine failed to change negative symptoms and had no effect on extrapyramidal symptoms. The exacerbation of schizophrenic symptoms may be explained by the antagonistic effects of this dose of D-cycloserine at the glycine recognition site of the NMDA receptor due to competition with the endogenous agonist glycine. Another explanation for the increase in psychopathology may be an interaction with the effects of antipsychotics on NMDA mediated neurotransmission. Thus, D-cycloserine in this study did not ameliorate schizophrenic symptoms. However, the fact that they actually worsened suggests that NMDA systems may be involved in the pathogenesis of schizophrenia. Further placebo-controlled studies with lower dosages of D-cycloserine, preferably in drug-free patients, are necessary to evaluate if D-cycloserine is of use for the treatment of patients with schizophrenia. (+info)N-methyl-D-aspartate receptor agonists modulate homocysteine-induced developmental abnormalities. (2/293)
We showed previously that the induction of neural crest (NC) and neural tube (NT) defects is a general property of N-methyl-D-aspartate receptor (NMDAR) antagonists. Since homocysteine induces NC and NT defects and can also act as an NMDAR antagonist, we hypothesized that the mechanism of homocysteine-induced developmental defects is mediated by competitive inhibition of the NMDAR by homocysteine. If this hypothesis is correct, homocysteine-induced defects will be reduced by NMDAR agonists. To test the hypothesis, we treated chicken embryos during the process of neural tube closure with sufficient homocysteine thiolactone to induce NC and NT defects in approximately 40% of survivors or with homocysteine thiolactone in combination with each of a selected set of NMDAR agonists in 0. 05-5000 nmol doses. Glutamate site agonists selected were L-glutamate and N-methyl-D-aspartate. Glycine site agonists were glycine, D-cycloserine, and aminocyclopropane-carboxylic acid. Glycine was the most effective overall, reducing defects significantly at two different doses (each P>0.001). These results support the hypothesis that homocysteine may affect NC and NT development by its ability to inhibit the NMDAR. One potentially important consequence of this putative mechanism is that homocysteine may interact synergistically with other NMDAR antagonists to enhance its effect on development. (+info)Flavone acetic acid induces a G2/M cell cycle arrest in mammary carcinoma cells. (3/293)
Flavone acetic acid (FAA) is a synthetic flavonoid that demonstrated extraordinary anti-tumour properties in murine models but was not effective in clinical trials. In an effort to better understand the molecular mechanisms by which FAA asserts its tumouricidal activities, we have examined the effect of FAA on the cell cycle. We observed FAA-mediated G2/M cell cycle arrest in mammary carcinoma cells at a concentration previously demonstrated to have anti-tumour effects in rodent models. The cell cycle arrest was accompanied by an increase in the P34cdc2 (cdc2) cyclin-dependent kinase activity. Morphological cytogenetic analysis demonstrated a colcemid-like effect of FAA on cytokinesis by causing accumulation of condensed C-metaphases of a sustained mitotic block. The cell cycle effect was blocked by the antioxidants ADPC and ascorbate, the superoxide scavenger Tiron, and the sphingosine kinase inhibitor L-cycloserine, but not by inhibitors of nitric oxide synthase. Based on these data, we propose that FAA may induce cell cycle arrest by stimulating the activity of acidic sphingomyelinase leading to the generation of reactive oxygen species. (+info)Induction of beta-lactamase influences the course of development in Myxococcus xanthus. (4/293)
Myxococcus xanthus is a gram-negative bacterium that develops in response to starvation on a solid surface. The cells assemble into multicellular aggregates in which they differentiate from rod-shaped cells into spherical, environmentally resistant spores. Previously, we have shown that the induction of beta-lactamase is associated with starvation-independent sporulation in liquid culture (K. A. O'Connor and D. R. Zusman, Mol. Microbiol. 24:839-850, 1997). In this paper, we show that the chromosomally encoded beta-lactamase of M. xanthus is autogenously induced during development. The specific activity of the enzyme begins to increase during aggregation, before spores are detectable. The addition of inducers of beta-lactamase in M. xanthus, such as ampicillin, D-cycloserine, and phosphomycin, accelerates the onset of aggregation and sporulation in developing populations of cells. In addition, the exogenous induction of beta-lactamase allows M. xanthus to fruit on media containing concentrations of nutrients that are normally too high to support development. We propose that the induction of beta-lactamase is an integral step in the development of M. xanthus and that this induction is likely to play a role in aggregation and in the restructuring of peptidoglycan which occurs during the differentiation of spores. In support of this hypothesis, we show that exogenous induction of beta-lactamase can rescue aggregation and sporulation of certain mutants. Fruiting body spores from a rescued mutant are indistinguishable from wild-type fruiting body spores when examined by transmission electron microscopy. These results show that the signal transduction pathway leading to the induction of beta-lactamase plays an important role in aggregation and sporulation in M. xanthus. (+info)Beta-cyanoalanine synthase: purification and characterization. (5/293)
Beta-cyano-L-alanine synthase [L-cysteine hydrogen-sulfide-lyase (adding HCN), EC 4.4.1.9] was purified about 4000-fold from blue lupine seedlings. The enzyme was homoegeneous on gel electrophoresis and free of contamination by other pyridoxal-P-dependent lyases. The enzyme has a molecular weight of 52,000 and contains 1 mole of pyridoxal-P per mole of protein; its isoelectric point is situated at pH 4.7. Its absorption spectrum has two maxima, at 280 and 410 nm. L-Cysteine is the natural primary (amino acid) substrate; beta-chloro- and beta-thiocyano can serve (with considerably lower affinity) instead of cyanide as cosubstrates for cyanoalanine synthase. The synthase is refractory to DL-cycloserine and D-penicillamine, potent inhibitors of many pyridoxal-P-dependent enzymes. Cyanoalanine synthase catalyzes slow isotopic alpha-H exchange in cysteine and in end-product amino acids; the rates of alpha-H exchange in nonreacted (excess) cysteine are markedly increased in the presence of an adequate cosubstrate; no exchange is observed of H atoms in beta-position. (+info)A possible involvement of ion transporter in tumor necrosis factor alpha and cycloheximide-induced apoptosis of endothelial cells. (6/293)
We examined the tumor necrosis factor alpha (TNFalpha)-induced apoptosis of vascular endothelial cells from the standpoint of ion channels. Cultured vascular endothelial cells from bovine carotid artery were used. Apoptosis was determined by a propidium iodide assay. Treatment of the endothelial cells with TNFalpha and cycloheximide for 6 h induced nuclear fragmentation in a TNFalpha dose-dependent manner (1-10 ng/ml). Concomitant treatment of endothelial cells with TNFalpha at a dose of 10 ng/ml and cycloheximide at a dose of 10 microg/ml elicited endothelial cell apoptosis as high as 23.4+/-4.1% at 6 h after administration. However, 10 ng/ml TNFalpha alone elicited a little apoptosis at 6 h after its administration (% apoptosis=4.1+/-0.8%). Cycloheximide (10 microg/ml) did not induce apoptosis at all. Concomitant treatment of endothelial cells with 1 mmol/l of 4,4-diisothiocyanatostilbene-2,2-disulfonic acid, which is a chloride bicarbonate exchanger blocker, partially inhibited the TNFalpha and cycloheximide-induced endothelial cell apoptosis. On the other hand, endothelial cell apoptosis due to TNFalpha and cycloheximide was completely inhibited by benzyloxycarbonyl-Asp-CH2OC(O)-2,6-dichlorobenzene (50 micromol/l), an inhibitor of caspase. Moreover, pyrrolidine dithiocarbanate, an inhibitor of nuclear factor kappa B (NF-kappaB), also suppressed endothelial cell apoptosis induced by TNFalpha and cycloheximide completely. These findings suggest that the endothelial cell apoptosis induced by TNFalpha and cycloheximide is closely related to not only chloride ions, but also both NF-kappaB and caspase activation. That is to say, there is a possibility that chloride ions or bicarbonate (pH) may play an important role in signal transduction such as NF-kappaB and caspase activation in the apoptosis induced by TNFalpha and cycloheximide. (+info)Characterization of a Mycobacterium smegmatis mutant that is simultaneously resistant to D-cycloserine and vancomycin. (7/293)
A mutant of Mycobacterium smegmatis has been isolated that is simultaneously resistant to both D-cycloserine (D-CS) and vancomycin. Genetic complementation with a PBP4 homolog restores sensitivity to both drugs. Resistance to D-CS and vancomycin in this mutant is most likely due to a novel mechanism involving peptidoglycan assembly at the cell surface. (+info)Intracellular modulation of NMDA receptor function by antipsychotic drugs. (8/293)
The present study deals with the functional interaction of antipsychotic drugs and NMDA receptors. We show that both the conventional antipsychotic drug haloperidol and the atypical antipsychotic drug clozapine mediate gene expression via intracellular regulation of NMDA receptors, albeit to different extents. Data obtained in primary striatal culture demonstrate that the intraneuronal signal transduction pathway activated by haloperidol, the cAMP pathway, leads to phosphorylation of the NR1 subtype of the NMDA receptor at (897)Ser. Haloperidol treatment is likewise shown to increase (897)Ser-NR1 phosphorylation in rats in vivo. Mutation of (896)Ser and (897)Ser to alanine, which prevents phosphorylation at both sites, inhibits cAMP-mediated gene expression. We conclude that antipsychotic drugs have the ability to modulate NMDA receptor function by an intraneuronal signal transduction mechanism. This facilitation of NMDA activity is necessary for antipsychotic drug-mediated gene expression and may contribute to the therapeutic benefits as well as side effects of antipsychotic drug treatment. (+info)
The partial NMDA agonist D-cycloserine stimulates LH secretion in healthy volunteers | SpringerLink
Cycloserine (CAS 68-41-7) Market Research Report 2017
CYCLOSERINE - ORAL (Seromycin) side effects, medical uses, and drug interactions.
proarmaturu.ru >> Cycloserine Online Pharmacies :: Cycloserine...
2016 Global and Chinese L-Cycloserine (CAS 339-72-0) Industry Market Research Report : ReportsnReports
Cycloserine Dimer CL4 Impurity | CAS No. 16337-02-3 - Veeprho : Reference Standards Manufacturer.
Cycloserine | Johns Hopkins ABX Guide
Augmentation of Psychotherapy With D-Cycloserine in Agoraphobia - Full Text View - ClinicalTrials.gov
Timeline of events during each exposure session. Abbrev | Open-i
Plus it
Oxamicina
-
Antibiotics, ATC:J04AB01
سیکلوسرین - ویکیپدیا
Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals With Schizophrenia - Tabular View -...
D-Cycloserine for anxiety disorders
Patent US5061721 - Composition containing d-cycloserine and d-alanine for memory and learning ... - Google Patents
2016 August | microrna inhibitor
D-cycloserine does not improve CBT for social anxiety disorder, but may accelerate early treatment gains
RCSB PDB
- 1MDZ: Crystal structure of ArnB aminotransferase with cycloserine and pyridoxal 5 phosphate Structure...
Donepezil overdose symptoms aricept parkinson s clomid pcos bfp prescription assistance for micardis
Where To Get Viagra In
Furosemide hypokalemia mechanism augmentin sospensione pediatrica aciclovir unguento labial lexapro awful
Nisheeta Lifesciences, INDIA
Olhando para cristo 579 cc pdf
D-cycloserine | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
Progressive Psychiatry
2i80 - Proteopedia, life in 3D
Society for Neuroscience - Memory-Boosting Drug May Help Cocaine Addicts Avoid Relapse
Enhancing Panic and Smoking Reduction Treatment with D-Cycloserine - Michael Otto
Detecting folding motifs and similarities in protein structures
r17) Barrick Lab :: ProtocolsFluctuationTests
Cycloserine capsules - AHealthyMe - Blue Cross Blue Shield of Massachusetts
Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial
...
DermIS - Vitamin B6 Deficiency (information on the diagnosis)
Treatments
EMF-Portal | GSM and DCS Wireless Communication Signals: Combined Chronic Toxicity/Carcinogenicity Study in the Wistar Rat.
EMF-Portal | GSM and DCS Wireless Communication Signals: Combined Chronic Toxicity/Carcinogenicity Study in the Wistar Rat.
D-Cycloserine
Sequence Similarity Search - BLAST
Sequence Similarity Search - BLAST
August 2019 - lightllightt0 xyz
Tuberculosis: Study describes new mutations in drug resistance - IHMT
JENIS OBAT KERAS : Antibiotik « Catfish Fabrication
Analytical Profiles of Drug Substances, Vol. 1 by FLOREY KLAUS - Portret de voluntar Book Archive
Essentiality of Mycobacterium tuberculosis D-alanine racemase - Ofelia Chacon
The efficacy of brief periods of reverse occlusion in promoting recovery from the physiological effects of mononuclear...
Incorporating the Judicious Use of Safety Behavior Into Exposure-Based Treatments for Anxiety Disorders: A Study of Treatment...
Immunology] searching for data on extinction coefficients for
equine seric Fab, F(ab)2
Cell Wall Inhibitors Antibiotics Flashcards
Bedaquiline - Drugs.com
Bedaquiline (Sirturo) | Daviss Drug Guide
Cycloserine
Under mildly acidic conditions, cycloserine hydrolyzes to give hydroxylamine and D-serine. Cycloserine can be conceptualized as ... Cycloserine is similar in structure to the amino acid D-alanine and works by interfering with the formation of the bacteria's ... Cycloserine was discovered in 1954 from a type of Streptomyces. It is on the World Health Organization's List of Essential ... Cycloserine works as an antibiotic by inhibiting cell-wall biosynthesis in bacteria. As a cyclic analogue of D-alanine, ...
Ligand-gated ion channel
D-cycloserine; L-aspartate; quinolinate, etc. Partial agonists : N-methyl-D-aspartic acid (NMDA); NRX-1074; 3,5-dibromo-L- ...
List of investigational antidepressants
"Cycloserine/lurasidone - NeuroRx". adisinsight.springer.com. Retrieved 7 May 2017. "Deudextromethorphan". adisinsight.springer. ... Cycloserine/lurasidone (NRX-101; Cyclurad) - NMDA receptor glycine site partial agonist and AA combination - specifically under ...
Karl August Folkers
His team also isolated the antibiotic cycloserine. In 1958 his Merck team determined the structure of coenzyme Q10. He later ...
Mycobacterium malmoense
Susceptible to ethambutol, ethionamide, kanamycin and cycloserine. Differential characteristics Antigenic structure: ...
2-Oxazolidone
Cycloserine is a second line drug against tuberculosis. Note that cycloserine, while technically an oxazolidone, has a ... The first ever used oxazolidinone was cycloserine (4-amino-1,2-oxazolidin-3-one), a second line drug against tuberculosis since ...
Streptomyces virginiae
... produces actithiazic acid, virginiamycins and cycloserine. Streptomyces virginiae also produces monensin ...
Ethionamide
When taken with cycloserine, seizures have been reported. High rates of hepatotoxicty have been reported when taken with ...
Traumatic memories
D-cycloserine is a chemical which enhances (agonist) the activity of the NMDA receptors. When used in rats, D-cycloserine was ... "Facilitation of Extinction of Conditioned Fear by D-Cycloserine. Implications for Psychotherapy". Current Directions in ...
Mycobacterium bohemicum
Sensitive to compounds such as prothionamide, cycloserine, clarithromycin, gentamicin, amikacin. Resistant to compounds such as ...
Terizidone
It is a derivate of cycloserine and it is bacteriostatic. Galietti F, Giorgis GE, Oliaro A, Boaro D, Ardizzi A, Barberis S, ...
Adolescence
Effects of D-Cycloserine". Neuropsychopharmacology. 35 (10): 2134-2142. doi:10.1038/npp.2010.92. PMC 3055297. PMID 20592716. ...
Tuberculosis management
... prothionamide cycloserine (WHO group 4) terizidone (WHO group 5) Third-line drugs (WHO group 5) include drugs that may be ... cycloserine); or it may be effective, but unavailable in many developing countries (e.g., fluoroquinolones):[citation needed] ... Cycloserine (80-100%) Ethionamide (100%) PAS (10-50%) (inflamed meninges only) The use of steroids is routine in TB meningitis ...
Social anxiety disorder
It has been shown that a combination of acute dosing of d-cycloserine (DCS) with exposure therapy facilitates the effects of ... Hofmann SG, Pollack MH, Otto MW (2006). "Augmentation Treatment of Psychotherapy for Anxiety Disorders with D-Cycloserine". CNS ... March 2006). "Augmentation of exposure therapy with D-cycloserine for social anxiety disorder". Arch. Gen. Psychiatry. 63 (3): ...
D-alanine-D-alanine ligase
Phosphinate and D-cycloserine are known to inhibit this enzyme. The N-terminal region of the D-alanine-D-alanine ligase is ...
Mycobacterium hassiacum
Susceptible to some antibiotics, including streptomycin, ethambutol, cycloserine, ciprofloxacin and clarithromycin. Resistant ...
Ailurophobia
D-cycloserine has been linked to facilitating better results in exposure therapy. Dorothy L. Sayers twice made use of ... "D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic ...
Blastopirellula marina
It's "resistant to ampicillin, penicillin, cephalothin, streptomycin, and cycloserine, but not tetracycline." Six strains have ...
Cell envelope antibiotic
Examples include cycloserine, penicillin, and polymyxin B. "Antibiotics that affect the cell envelope". v t e (Articles with ...
Specific phobia
As of 2020, studies on the use of adjunct d-cycloserine are inconclusive. The majority of those that develop a specific phobia ... There are some findings suggesting that adjuvant use of the NMDA receptor partial agonist, d-cycloserine, with virtual reality ...
List of biochemists
Karl August Folkers (1906-1997). American biochemist at Merck, known for work on the antibiotics cathomycin and cycloserine. ...
Stefan Hofmann
Hofmann has shown that d-cycloserine, a partial agonist of the glutamate receptor can augment extinction learning and speed up ... doi:10.1038/mp.2015.109 Hofmann, S. G. (2016). Schrödinger's cat and d-cycloserine to augment exposure therapy - both are dead ... Hofmann, Stefan (2016). "Schrödinger's cat and d-cycloserine to augment exposure therapy - both are dead and alive". JAMA ... ". "Cognitive Therapy and Research". Hofmann, Stefan G. (March 2014). "D-cycloserine for Treating Anxiety Disorders: Making ...
GABA transaminase inhibitor
... and L-cycloserine. Certain members of this class are used as anticonvulsants. Ciesielski, L.; Simler, S.; Gensburger, C.; ... "L-cycloserine: Behavioural and biochemical effects after single and repeated administration to mice, rats and cats". ...
University of Florida Obsessive Compulsive Disorder Program
"A Preliminary Study of D-Cycloserine Augmentation of Cognitive-Behavioral Therapy in Pediatric Obsessive-Compulsive Disorder". ...
Aeropyrum pernix
The cells of the organisms are sensitive to chloramphenicol and insensitive to ampicillin, vancomycin, and cycloserine. It ...
Alanine racemase
At least two compounds, 3-Fluoro-D-alanine and D-Cycloserine are known to inhibit this enzyme. The D-alanine produced by ...
Vitamin B6
Use of oral contraceptives and treatment with certain anticonvulsants, isoniazid, cycloserine, penicillamine, and ...
Quinolone antibiotic
... and cycloserine. Administration of quinolone antibiotics to a benzodiazepine-dependent individual can precipitate acute ...
Mycobacterium branderi
In susceptibility tests the type strain was resistant to isoniazid, rifampin, pyrazinamide, and cycloserine but susceptible to ...
Mycobacterium mageritense
Optimum growth at 30 °C and 37 °C. Resistant to isoniazid, cycloserine, capreomycin, pyrazinamide, and thiosemicarbazone Most ...
D-Cycloserine for Social Anxiety: Does Timing Matter?
D-cycloserine appears to augment exposure therapy for social anxiety disorder. But does timing of the drug matter? ... D-cycloserine (DCS), an antibiotic that has traditionally been used to treat tuberculosis, appears to augment exposure therapy ... Cite this: D-Cycloserine for Social Anxiety:Does Timing Matter? - Medscape - Jun 04, 2020. ...
Common and Rare Side Effects for Cycloserine
Find out what health conditions may be a health risk when taken with Cycloserine ... Cycloserine. Common Brand(s): Seromycin Generic Name(s): cycloserine View Free Coupon ... Who should not take Cycloserine? The following conditions are contraindicated with this drug. Check with your physician if you ... Should I avoid certain foods while taking Cycloserine? * What should I know regarding pregnancy, nursing and administering ...
Deterioration of cycloserine in the tropics*
Cycloserine: Uses, Interactions, Mechanism of Action | DrugBank Online
Cycloserine is a broad-spectrum antibiotic used in the treatment of tuberculosis and certain urinary tract infections (UTI). ... Cycloserine. Cycloserine (250 mg/1). Capsule. Oral. Macleods Pharmaceuticals Limited. 2019-01-18. Not applicable. US. ... Cycloserine may increase the neurotoxic activities of Acetophenazine.. Alimemazine. Cycloserine may increase the neurotoxic ... Cycloserine may increase the neurotoxic activities of Amisulpride.. Amitriptyline. Cycloserine may increase the neurotoxic ...
Treatment of Tuberculosis and Tuberculosis Infection in Adults and Children
Cycloserine. Like ethionamide, cycloserine is a bacteriostatic antituberculosis agent that is useful in certain limited ... For this reason 150 mg/d of pyridoxine should be given with cycloserine. Cycloserine interferes with the elimination of ... Cycloserine. Capreomycin. Kanamycin. Thiacetazone. POTENTIALLY EFFECTIVE DRUGS THAT HAVE NOT BEEN WIDELY USED IN THE THERAPY OF ... There is not enough information to determine the risk of cycloserine or ethionamide; they should be avoided if possible. ...
Search
No Effects of D-Cycloserine Enhancement in Exposure with Response Prevention Therapy in Panic Disorder with Agoraphobia: A...
Purpose/Background D-cycloserine (DCS) is a partial N-methyl-D-aspartate receptor agonist that potentially augments response to ... No Effects of D-Cycloserine Enhancement in Exposure with Response Prevention Therapy in Panic Disorder with Agoraphobia: A ... No Effects of D-Cycloserine Enhancement in Exposure with Response Prevention Therapy in Panic Disorder with Agoraphobia: A ... Keywords: D-cycloserine, enhancement, panic disorder with agoraphobia, posttreatment, pretreatment, Psychiatry and Mental ...
D-Cycloserine (D-CSR) - Krins Life Sciences
CAS No. 68-41-7 HSN Code : 29379020 IMDG Identification : Not Regulated for Transport (Non-Haz) Molecular Formula : C3H6N2O2 Molecular Weight : 102.09 Storage : 2 to 8°C (Refrigerate) Shelf Life : 60 Months Specifications Appearance (Colour) White to pale yellow Appearance (Form) Powder Potency min. 900 units/mg Not for…
August Testing - Reports | MPEP | Laboratory Information | TB | CDC
Specimen collection and processing instructions for CYCLOSERINE, LEVEL test
Hereditary Coproporphyria Treatment & Management: Approach Considerations, Diet, Prevention
Opposing effects of d-cycloserine on fear despite a common extinction duration: Interactions between brain regions and behavior...
Using Cognitive Enhancers to Improve the Treatment of Anxiety Disorders in Young People: Examining the Potential for D...
This article examines the potential use of D-cycloserine (DCS) to augment exposure-based therapies for anxious young people. ... This article examines the potential use of D-cycloserine (DCS) to augment exposure-based therapies for anxious young people. ... medications like D-cycloserine (DCS) to improve conventional psychological therapies. Exposure therapies relying upon the ... Examining the Potential for D-Cycloserine to Augment Exposure for Child Anxiety. ...
دی سیکلو سرین 30020 سیگما / D-Cycloserine 30020 Sigma - کیان پرتو تجهیز
Bedaquiline - Wikipedia
The most common side effects of bedaquiline in studies were nausea, joint and chest pain, and headache. The drug also has a black-box warning for increased risk of death and arrhythmias, as it may prolong the QT interval by blocking the hERG channel.[18] Everyone on bedaquiline should have monitoring with a baseline and repeated ECGs.[19] If a person has a QTcF of , 500 ms or a significant ventricular arrythmia, bedaquiline and other QT prolonging drugs should be stopped.[citation needed] There is considerable controversy over the approval for the drug, as one of the largest studies to date had more deaths in the group receiving bedaquiline that those receiving placebo.[20] Ten deaths occurred in the bedaquiline group out of 79, while two occurred in the placebo group, out of 81.[15] Of the 10 deaths on bedaquiline, one was due to a motor vehicle accident, five were judged as due to progression of the underlying tuberculosis and three were well after the person had stopped receiving ...
D-Serine and D-Cycloserine Reduce Compulsive Alcohol Intake in Rats. | Neuropsychopharmacology;40(10): 2357-67, 2015 Sep. |...
Systemic D-cycloserine also selectively reduced intake of quinine-adulterated alcohol, and D-cycloserine inhibited NAcore HA- ... D-Serine and D-Cycloserine Reduce Compulsive Alcohol Intake in Rats.. Seif, Taban; Simms, Jeffrey A; Lei, Kelly; Wegner, Scott ... D-serine and D-cycloserine, the NMDAR activators at the glycine site, are of particular interest because they have been used in ... cycloserine on this aversion-resistant alcohol intake (that persists despite adulteration with quinine) and consumption of ...
Niacinamide: MedlinePlus Supplements
Tuberculosis (TB) Treatment & Management: Approach Considerations, Treatment During Pregnancy, Treatment in Children
Tuberculosis (TB) (see the image below), a multisystemic disease with myriad presentations and manifestations, is the most common cause of infectious disease-related mortality worldwide. Although TB rates are decreasing in the United States, the disease is becoming more common in many parts of the world.
D-cycloserine improves synaptic transmission in an animal mode of Rett syndrome<...
D-cycloserine improves synaptic transmission in an animal mode of Rett syndrome. PloS one. 2017 Aug;12(8):e0183026. doi: ... D-cycloserine improves synaptic transmission in an animal mode of Rett syndrome. In: PloS one. 2017 ; Vol. 12, No. 8. ... D-cycloserine improves synaptic transmission in an animal mode of Rett syndrome. / Na, Elisa S.; De Jesús-Cortés, Héctor; ... Treatment of Mecp2tm1.1Jae/y mice with D-cycloserine (DCS), an FDA-approved analog of the amino acid D-alanine with antibiotic ...
NEW (2008) DeCS DESCRIPTORS WITH SCOPE NOTES (UNIT RECORD FORMAT; 21/02/2008
The effect of D-cycloserine on brain processing of breathlessness over pulmonary rehabilitation - an experimental medicine...
Reticular formation and spinal cord injury | Spinal Cord
Fear Not
Use of D-cycloserine could partially overcome those obstacles, he says.. Davis predicts that the drug could also treat people ... D-cycloserine also binds to the NMDA receptor and, according to animal studies, enhances learning. Physicians have been so ... Injecting D-cycloserine into a rodents bloodstream or amygdala before this training sped up the extinction process, the ... Davis started his investigation of D-cycloserines effect on fear by conditioning rats to associate a foot shock with a bright ...
Tourette's Syndrome Clinical Research Trials | CenterWatch
Boehm GW[au] - Search Results - PubMed
Anti-Mycobacteria | GoldBio
AntibioticEthambutolAmino acidBacteriaInhibits2017TuberculosisExposureAlcoholEnzymesResistantDepressionDrugWorksIncreaseSiteTreatmentEthionamideAmikacinSeromycinFructose AgarNMDAAgarCell-wall synthesisIsoniazidMycobacteriaAgonistToxicityBroad-spectrum a250mgPharmacokineticsGram-negativeExtinction of fearGlycine siteDrugsFear extinctionEfficacyInhibitorDoseMolecularConcentrationsDeficitsSchizophreniaPlacebo-controlledCognitiveSubunitsFacilitateSevereEffects
Antibiotic10
- D-cycloserine (DCS), an antibiotic that has traditionally been used to treat tuberculosis, appears to augment exposure therapy (ET) for social anxiety disorder (SAD) regardless of whether it's administered before or after a session, new research suggests. (medscape.com)
- Cycloserine is a broad-spectrum antibiotic used in the treatment of tuberculosis and certain urinary tract infections (UTI). (drugbank.com)
- Cycloserine, a broad-spectrum antibiotic, may be bactericidal or bacteriostatic, depending on its concentration at the site of infection and the susceptibility of the organism. (drugbank.com)
- Treatment of Mecp2 tm1.1Jae/y mice with D-cycloserine (DCS), an FDA-approved analog of the amino acid D-alanine with antibiotic and glycinergic activity, corrected the presynaptic but not LTP deficit without affecting deficient hippocampal BDNF levels. (elsevier.com)
- D-Cycloserine is an amino acid analog antibiotic effective against a wide variety of bacteria. (goldbio.com)
- Led by professor David Roper at the University of Warwick's School of Life Sciences and Dr Luiz Pedro Carvalho from the Francis Crick Institute, a paper published today in Nature Communications reveals a deeper understanding of how the antibiotic D-cycloserine uniquely works at a molecular level. (infectioncontroltoday.com)
- D-cycloserine is an old antibiotic drug which is effective against many microbial diseases such as tuberculosis, but is often used as a second line treatment, because of some adverse side-effects. (infectioncontroltoday.com)
- Dr, Luiz Pedro Carvalho, from the Mycobacterial Metabolism and Antibiotic Research Laboratory at the Francis Crick Institute, said, 'Perhaps more important than how D-cycloserine works, this study highlights an increasingly obvious fact: we know much less than we think about how antibiotics really work and how bacteria become resistant. (infectioncontroltoday.com)
- A longer term goal will be to modify the structure of D-cycloserine, so that it more closely resembles the newly discovered chemical species, and in so doing produce an antibiotic that is more specific and avoids some of adverse side effects of D-cycloserine - enabling its wider use in the fight against antibiotic resistant infections. (infectioncontroltoday.com)
- Sarah Batson et al, Inhibition of D-Ala:D-Ala ligase through a phosphorylated form of the antibiotic D-cycloserine, Nature Communications (2017). (medicalxpress.com)
Ethambutol2
- On the 20th day of admission, therefore, rifampicin and ethambutol treatments of the girl were stopped, and anti-tuberculosis treatment was readjusted to high doses of isoniazid (15 mg/kg once daily), pyrazinamide (30 mg/kg/day), amikacin (15 mg/kg/day), levofloxacin (10 mg/kg twice daily), linezolid (10 mg/kg twice daily), cycloserine (15 mg/kg once daily) and clofazimine (5 mg/kg once daily) (8). (who.int)
- Currently the patient was on Isoniazid, Rifampicin, Ethambutol, Pyrazinamide and also on Kanamycin, Clofazimine and Cycloserine since past 3 months. (pediatriconcall.com)
Amino acid1
- Cycloserine is an analog of the amino acid D-alanine. (drugbank.com)
Bacteria2
- This is an impression smear photomicrograph of darkly-stained, rod-shaped, Clostridium difficile bacteria, grown on cycloserine-mannitol blood agar. (cdc.gov)
- Perhaps more important than how D-cycloserine works, this study highlights an increasingly obvious fact: we know much less than we think about how antibiotics really work and how bacteria become resistant. (medicalxpress.com)
Inhibits2
- D-cycloserine inhibits a variety of enzymes, is a partial NMDA receptor agonist, and may improve memory and cognition. (goldbio.com)
- The researchers have observed, for the first time, how D-cycloserine inhibits the D-alanine-D-alanine ligase enzyme. (infectioncontroltoday.com)
20171
- A 2017 meta-analysis of 21 studies found that d-cycloserine was superior to a placebo in boosting the short-term effect of exposure-based therapy, though any long-term effects were less consistent. (maps.org)
Tuberculosis1
- In other prescription drug news, a huge price hike for tuberculosis drug cycloserine has been withdrawn, the Times reports . (moneytalksnews.com)
Exposure4
- Purpose/Background D-cycloserine (DCS) is a partial N-methyl-D-aspartate receptor agonist that potentially augments response to exposure therapy in anxiety disorders by enhancing extinction learning. (uu.nl)
- This article examines the potential use of D-cycloserine (DCS) to augment exposure-based therapies for anxious young people. (edu.au)
- They randomly assigned the participants to virtual reality exposure (12 weekly sessions of simulated attacks on the World Trade Center combined with patients' recounting their traumatic experience in vivid detail) with either the drug d-cycloserine or a placebo. (maps.org)
- Subjects who received exposure along with d-cycloserine showed faster and greater improvement in their PTSD and depressive symptoms, and the benefits persisted after six months of follow-up. (maps.org)
Alcohol4
- D-Serine and D-Cycloserine Reduce Compulsive Alcohol Intake in Rats. (bvsalud.org)
- Here, we examined the impact of D- serine and D- cycloserine on this aversion-resistant alcohol intake (that persists despite adulteration with quinine ) and consumption of quinine -free alcohol. (bvsalud.org)
- Systemic D- cycloserine also selectively reduced intake of quinine -adulterated alcohol, and D- cycloserine inhibited NAcore HA-NMDARs in vitro . (bvsalud.org)
- Our results indicate that HA-NMDAR modulators can reduce aversion-resistant alcohol drinking , and support testing of D- serine and D- cycloserine as immediately accessible, FDA-approved drugs to treat AUDs. (bvsalud.org)
Enzymes1
- D-Cycloserine acts as inhibitor of various enzymes. (kianpartotadjhiz.com)
Resistant1
- Spores of ''B. clausii'' are resistant to many antibiotics including erythromycin, lincomycin, cephalosporins, and cycloserine. (kenyon.edu)
Depression1
- Low-Dose d-Cycloserine for depression? (umn.edu)
Drug1
- Rodelis Therapeutics recently acquired the drug and then proceeded to increase the price of 30 pills of cycloserine from $500 to $10,800. (moneytalksnews.com)
Works1
- Cycloserine works by blocking the formation of these peptidoglycans. (drugbank.com)
Increase1
- Cycloserine may increase the neurotoxic activities of Acetophenazine. (drugbank.com)
Site1
- D- serine and D- cycloserine , the NMDAR activators at the glycine site, are of particular interest because they have been used in humans without serious adverse effects . (bvsalud.org)
Treatment1
- A promising development in the treatment of anxiety disorders is the use of "cognitive-enhancing" medications like D-cycloserine (DCS) to improve conventional psychological therapies. (edu.au)
Ethionamide3
- Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients. (nih.gov)
- ethionamide, cycloserine. (medscape.com)
- Monitor Closely (1) ethionamide, cycloserine. (medscape.com)
Amikacin2
- 2} In this child since all the first line drugs were resistant, the child was treated with amikacin, cycloserine, PAS, clofazamine and linezolid. (pediatriconcall.com)
- On the 20th day of admission, therefore, rifampicin and ethambutol treatments of the girl were stopped, and anti-tuberculosis treatment was readjusted to high doses of isoniazid (15 mg/kg once daily), pyrazinamide (30 mg/kg/day), amikacin (15 mg/kg/day), levofloxacin (10 mg/kg twice daily), linezolid (10 mg/kg twice daily), cycloserine (15 mg/kg once daily) and clofazimine (5 mg/kg once daily) (8). (who.int)
Seromycin1
- Cycloserine, chemically known as 4-amino-3-isoxazolidinone is a nootropic drug that is vended under the name Seromycin. (armodexperiment.com)
Fructose Agar3
- Cycloserine Cefoxitin Fructose Agar with Lysozyme (CCFA-L) is an enriched, selective, and differential media used for the isolation and presumptive identification of Clostridium difficile , a recognized cause of pseudomembranous (antimicrobial agent-associated) colitis. (anaerobesystems.com)
- Included Direct Culture onto Cycloserine Cefoxitin Fructose Agar and Enriched Culture Using Cycloserine Cefoxitin Mannitol Broth with Taurocholate and Lysozyme. (elsevier.com)
- C. difficile toxin-positive stool specimens, in 1-mL aliquots, were shipped frozen to the Centers for Disease Control and Prevention (Atlanta, GA, USA) anaerobe laboratory for culturing by direct inoculation onto cycloserine cefoxitin fructose agar (CCFA) or ethanol shock, followed by CCFA inoculation. (cdc.gov)
NMDA6
- Peripheral injections of D-cycloserine, a partial agonist of the glycine site on the NMDA receptor which crosses the blood-brain barrier, also doubles rabbits' learning rates. (northwestern.edu)
- A role beyond learning for NMDA receptors in reward-based decision-making-a pharmacological study using d-cycloserine. (ox.ac.uk)
- Human participants were assigned to receive either 250 mg of the partial NMDA agonist d-cycloserine (n=20) or matching placebo capsules (n=27). (ox.ac.uk)
- Facilitation of NMDA receptor function by NMDA receptor glycine-site agonists such as D-cycloserine and glycine is effective on the abnormal intracellular signaling, and emotional and cognitive deficits in mice treated with PCP repeatedly. (nih.gov)
- NRX-101 combines D-cycloserine (DCS), an N-methyl-D-aspartate (NMDA) receptor antagonist, and lurasidone , a D 2 /5-HT 2a receptor antagonist. (empr.com)
- Even though our understanding is quite limited, in schizophrenia and other neuropsychiatric disorders, significant efforts have been made to clinically enhance NMDA receptor activity though this co-agonist site, either directly by high-dose administration of glycine, D-serine or D-cycloserine (a partial agonist) or indirectly though inhibition of glycine transporters or D-amino acid oxidase. (ucdavis.edu)
Agar2
- Tryptose Sulfite Cycloserine (TSC) Agar is a selective and differential medium used for the detection and counting of vegetative cells and spores of Clostridium perfringens by membrane filtration method (ISO 14189) in samples of water intended for human consumption or for inoculation in food samples. (generon-food-safety.com)
- This is an impression smear photomicrograph of darkly-stained, rod-shaped, Clostridium difficile bacteria, grown on cycloserine-mannitol blood agar. (cdc.gov)
Cell-wall synthesis1
- Cycloserine is a d-alanine analogue of isoxazolidone that was isolated initially from Streptococcus orchidaceus and has moderate activity in vitro against mycobacterial species, probably acting by inhibition of mycobacterial use of amino acids and inhibition of cell wall synthesis. (nih.gov)
Isoniazid3
- Cycloserine was approved for use in the United States in 1964, but its use for most indications has been replaced by more modern antituberculosis agents except in instances of multidrug resistance or of intolerance to the more potent agents such as isoniazid, rifampin and pyrazinamide. (nih.gov)
- Use of drugs such as isoniazid, cycloserine, penicillamine, hydralazine and levodopa which induces increased requirement for vitamin B 6 . (mims.com)
- En standard tuberkulose behandling indledes med en kombination af fire antibiotika, rifampicin, isoniazid, pyrazinamid og ethambutol. (medicin.dk)
Mycobacteria1
- Cycloserine clinical laboratory standard powder is available for both direct and indirect methods1 of determining the susceptibility of strains of mycobacteria. (nih.gov)
Agonist3
- Previous research has demonstrated that systemic D-cycloserine (DCS), a partial agonist of the N-methyl-D-aspartate receptor (NMDAR), enhances memory processes in different learning paradigms and attenuates mnemonic deficits produced by diverse pharmacological manipulations. (sigmaaldrich.com)
- Here, we describe the cocrystal structures of the NR1 S1S2 ligand-binding core with the agonists glycine and D-serine (DS), the partial agonist D-cycloserine (DCS) and the antagonist 5,7-dichlorokynurenic acid (DCKA). (rcsb.org)
- Different affinity to the NR3 subunits was observed for the partial agonist D-cycloserine and the antagonist 7-chloro-kynurenate, which could not displace [3H]-glycine from NR3A (paper III), but from NR3B (paper IV). (avhandlingar.se)
Toxicity1
- The toxicity of cycloserine is closely related to excessive blood levels (above 30 μg/mL), as determined by high dosage or inadequate renal clearance. (nih.gov)
Broad-spectrum a1
- Cycloserine, 3-isoxazolidinone, 4-amino -, (R)- is a broad-spectrum antibiotic that is produced by a strain of Streptomyces orchidaceus and has also been synthesized. (nih.gov)
250mg1
- clopidogrel 75 mg tablet , clotrimazole 1% cream / oint , codeine lintus 15 mg / 5 ml syrup , containing urea i.p. + lactic acid + propylene glycol i.p. + liquid paraffin cream cream , cycloserine 250mg capsule , dapagliflozin 10 mg tablet , deflazacort 30 mg tablet , deflazacort 6 mg tablet , dexamethason 4 mg tab. (tendersindelhi.com)
Pharmacokinetics1
- The pharmacokinetics of cycloserine were minimally affected by orange juice and antacids, whereas the high-fat meal delayed absorption. (medscape.com)
Gram-negative2
- Cycloserine may be effective in the treatment of acute urinary tract infections caused by susceptible strains of gram-positive and gram-negative bacteria, especially Enterobacter spp. (nih.gov)
- Cycloserine will inhibit gram-negative bacteria, while cefoxitin will inhibit both gram-positive and gram-negative organisms. (anaerobesystems.com)
Extinction of fear1
- 9. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. (nih.gov)
Glycine site1
- Further, the use of NMDAR glycine site agonists such as glycine, d -serine, or d -cycloserine in clinical trials has demonstrated some efficacy in ameliorating the negative symptoms and cognitive disabilities in schizophrenics ( Coyle and Tsai 2004a , 2004b ). (nih.gov)
Drugs2
- Like all antituberculosis drugs, cycloserine should be administered in conjunction with other effective chemotherapy and not as the sole therapeutic agent. (nih.gov)
- One is the use of drugs like d-cycloserine to enhance extinction learning. (cogneurosociety.org)
Fear extinction1
- D-cycloserine enhances generalization of fear extinction in children. (sigmaaldrich.com)
Efficacy1
- In addition, a mixture of DAs enhanced antimicrobial efficacy of D-Cycloserine (DCS) up to 32% as compared with DCS treatment alone. (edu.au)
Inhibitor1
- D-Cycloserine acts as inhibitor of various enzymes. (sigmaaldrich.com)
Dose4
- To determine the effect of a high-fat meal, orange juice, and antacids on absorption of a single oral dose of cycloserine and to estimate its population pharmacokinetic parameters. (medscape.com)
- Approximately 65 percent of a single dose of cycloserine can be recovered in the urine within 72 hours after oral administration. (nih.gov)
- Cycloserine is reported to be associated with a low rate of serum aminotransferase elevations that are usually transient and asymptomatic and do not require dose modification. (nih.gov)
- Dose-finding trial of d-cycloserine added to neuroleptics for negative symptoms in schizophrenia. (harvard.edu)
Molecular1
- The molecular weight of cycloserine is 102.09, and it has an empirical formula of C3H6N2O2. (nih.gov)
Concentrations2
- Therefore, it is important to clarify dosing conditions that may impair or promote achievement of adequate cycloserine plasma concentrations. (medscape.com)
- The basic nutritive base consists of animal peptones and fructose and is supplemented with cefoxitin and cycloserine at concentrations that inhibit the growth of most normal fecal flora. (anaerobesystems.com)
Deficits2
- D-cycloserine prevents relational memory deficits and suppression of long-term potentiation induced by scopolamine in the hippocampus. (sigmaaldrich.com)
- D-Cycloserine ameliorates autism-like deficits by removing GluA2-containing AMPA receptors in a valproic acid-induced rat model. (ym.edu.tw)
Schizophrenia2
- A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. (harvard.edu)
- D-cycloserine added to clozapine for patients with schizophrenia. (harvard.edu)
Placebo-controlled1
- Augmenting extinction learning with d-cycloserine reduces return of fear: A randomized, placebo-controlled fMRI study. (mpg.de)
Cognitive3
- D-cycloserine augmentation of cognitive behavioral therapy for anxiety disorders: an update. (sigmaaldrich.com)
- The Future of D-Cycloserine and Other Cognitive Modifiers in Obsessive-Compulsive and Related Disorders. (sigmaaldrich.com)
- Presentations included an informative history of exposure therapy and related advances in anxiety disorder treatments, the use of D-Cycloserine for boosting the effects of an intervention, and the role of sudden gains and therapeutic alliance in cognitive behavioral therapy (CBT). (nih.gov)
Subunits1
- When taking into account the use of knockout animals, it is important L-Cycloserine to acknowledge that deficiency in cytokine or receptor subunits may impact more than one particular cytokine as outlined in Figure 3B. (annumed.net)
Facilitate1
- D-cycloserine (DCS) may facilitate treatment gains by increasing generalization of extinction learning, however, its effects have not been tested in children. (sigmaaldrich.com)
Severe1
- Allergic reactions have been reported with cycloserine and, if severe, these may be accompanied by mild serum enzyme elevations. (nih.gov)
Effects3
- Effects of food, acidic beverages, or antacids on the pharmaco-kinetics of cycloserine have not been evaluated in a crossover study. (medscape.com)
- Effects of D-cycloserine on extinction: translation from preclinical to clinical work. (sigmaaldrich.com)
- rarely, cycloserine causes more serious neurological side effects such as acute psychosis, seizures and coma. (nih.gov)